Suvretta Capital Management »

Scpharmaceuticals shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Scpharmaceuticals (SCPH) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Scpharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Scpharmaceuticals held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scpharmaceuticals by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.5M 1.8M 3.54
2024-09-30 $9.3M 2.0M 4.56

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcutis Biotherapeutics (ARQT)
Benitec Biopharma Com New (BNTC)
Meta Platforms Cl A (META)
Legend Biotech Corp Sponsored Ads (LEGN)
89bio (ETNB)
Immatics SHS (IMTX)
Coca-Cola Company (KO)
Ge Aerospace Com New (GE)
NVIDIA Corporation (NVDA)
Eyepoint Pharmaceuticals Com New (EYPT)
Biohaven (BHVN)
Mineralys Therapeutics (MLYS)
Home Depot (HD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Suvretta Capital Management

Top funds holding Scpharmaceuticals

OrbiMed Advisors
Rubric Capital Management
Weiss Asset Management LP[1
BlackRock
Vanguard Group
Tudor Investment Corporation
Morgan Stanley
Luther King Capital Management Corporation
Hsbc Holdings
Glazer Capital
Alpine Associates Management
Newtyn Management
Geode Capital Management
Nantahala Capital Management
State Street Corporation

View all funds holding Scpharmaceuticals